A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer

NACompletedINTERVENTIONAL
Enrollment

669

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

February 16, 2018

Study Completion Date

February 16, 2018

Conditions
Ovarian Cancer
Interventions
OTHER

CA 125 and CT scan

Within 14 days prior to surgery serum for CA125 will be obtained. The patient will also undergo a CT scan of the abdomen and pelvis with oral and intravenous contrast within 35 days prior to the procedure.

Trial Locations (5)

10065

Memorial Sloan Kettering Cancer Center, New York

11725

Memorial Sloan Kettering Cancer Center @ Suffolk, Commack

21287

The Johns Hopkins Hospital, Baltimore

77030

Md Anderson Cancer Center, Houston

Unknown

Memoral Sloan Kettering Cancer Center, Basking Ridge

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00587093 - A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer | Biotech Hunter | Biotech Hunter